Quick Heal Technologies Ltd Q1 FY27 Earnings Analysis
Published 1 Jul 2026 | IT - Software | Market Cap: ₹1.1K Cr
Price
₹173
Market Cap
₹1.1K Cr
P/E Ratio
196.4
Revenue Rank
Margin Rank
How does Quick Heal Technologies Ltd rank in IT - Software?
Compare Quick Heal Technologies Ltd against every IT - Software company this quarter on revenue, margins and earnings-call signals.
Quick Heal Technologies Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹49 Cr, net profit ₹-20 Cr.
Full financials →Earnings Summary
- Quick Heal anticipates the enterprise vertical to be the primary growth driver over the next 2-3 years, targeting it to comprise 80-90% of revenue. - Quick Heal is undergoing a transition from a B2C antivirus to a holistic cybersecurity company, focusing on enterprise business.
📊 Revenue & Sales Performance
Rank 3- →Quick Heal anticipates the enterprise vertical to be the primary growth driver over the next 2-3 years, targeting it to comprise 80-90% of revenue.
- →Enterprise business showed consistent growth, especially in government and BFSI segments, supported by increased deferred revenue and a strong order book.
- →Strategic investments are being made to expand in South East Asia, Middle East, Africa, and Latin America.
- →Cloud adoption in security solutions is increasing rapidly, now contributing 40% to EPP and EDR deployments, up from 20% two years ago.
- →New offerings like Digital Risk Protection Services (DRPS), Ransomware Recovery as a Service (RRAS), and data privacy solutions are expected to gain traction with increased regulatory compliance needs.
- →Consumer business continues to face headwinds with expected short-term pressures; however, leadership in this segment is maintained.
- →Overall, the company sees a transitionary phase with growth resuming post two quarters, backed by investments in AI, product innovation, and market expansion.
📈 Profitability & Margins
Rank 3- →Quick Heal is undergoing a transition from a B2C antivirus to a holistic cybersecurity company, focusing on enterprise business.
- →Enterprise vertical now represents over 50% of revenue, expected to grow to 80-90% within 2-3 years (Ankit Maheshwari & Kailash Katkar).
- →Consumer business faces headwinds, with revenues expected to face some short-term pressure, especially in next 1-2 quarters.
- →EBITDA and PAT turned negative due to revenue decline and fixed cost structure; however, management expects this phase to last a maximum of two quarters.
- →Investments in AI, data privacy, and cloud security are key growth drivers supporting future profitability.
- →Revenue growth is anticipated from new products like EDR, XDR, DRPS, ransomware recovery, and data privacy solutions.
- →The company maintains a strong, debt-free balance sheet, allowing continued R&D and market expansion.
- →Overall, management is confident of sustainable growth and profitability in the medium term despite near-term challenges.
🏗️ Capital Expenditure Plans
No information- →The company continues to invest significantly in R&D, fully expensing these investments in the year incurred.
- →Strategic investments have been made in expanding market presence in South East Asia, Middle East Africa, and Latin America.
- →Investment focus on AI-driven technologies, threat intelligence, data privacy, and scalable global capabilities to stay ahead in the cybersecurity industry transformation.
- →There is a clear emphasis on Make in India initiatives targeting government business and international penetration.
- →The company remains debt-free with a strong balance sheet, providing flexibility for ongoing investments in R&D and market expansion.
- →No explicit mention of specific current or future capex figures, but the strategic roadmap highlights continual investment in product innovation and global growth.
💰 Fundraising & Capital Structure
No information- →The company currently has a strong and debt-free balance sheet, providing flexibility for investments.
- →There is no mention of any new fundraising plans through debt or equity in the call.
- →Focus remains on investing in R&D and market expansion using existing cash and investments.
- →Cash and investments stood at Rs. 249 crores as of the latest update.
- →Management did not indicate any intent or plan to raise external capital at this stage.
📋 Order Book & Pipeline
Yes- →Current order book stands at Rs. 55 crores for FY’26, up from Rs. 6 crores in FY’25.
- →Deferred revenue increased to Rs. 34 crores from Rs. 14 crores in the previous year.
- →Successfully executed a cyber literacy order received in February 2025.
- →Secured an additional order worth Rs. 64 crores related to the implementation of integrated cybersecurity solutions.
- →The order book reflects strong confidence in the company's transformation into a holistic cybersecurity solutions provider.
- →Growth driven largely by robust momentum in the government segment.
Key Metrics
Revenue
Margin
Capex
Fundraise
Order Book
Frequently Asked Questions
What were Quick Heal Technologies Ltd Q1 FY27 results?
- Quick Heal anticipates the enterprise vertical to be the primary growth driver over the next 2-3 years, targeting it to comprise 80-90% of revenue. - Quick Heal is undergoing a transition from a B2C antivirus to a holistic cybersecurity company, focusing on enterprise business.
What is Quick Heal Technologies Ltd share price analysis?
Quick Heal Technologies Ltd currently shows a below-average growth signal. The stock trades at a P/E of 196.4 with a market cap of ₹1,131. Investors should review the full earnings analysis for detailed insights.
Is Quick Heal Technologies Ltd planning capital expenditure?
- The company continues to invest significantly in R&D, fully expensing these investments in the year incurred.
Keep Quick Heal Technologies Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.